Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
NCT00202514Phase 3Completed
- Sponsor
- Seattle Institute for Biomedical and Clinical Research
- Start
- Sep 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of divalproex sodium in alcohol dependence (2 arms), sponsored by Seattle Institute for Biomedical and Clinical Research. Primary endpoint: Symptom Checklist-90-Revised at 12 weeks. Started Sep 2004; status: completed.
02
Drugs
divalproex sodium
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00202514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00202514.